Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 16.31 M14.86 M13.7 M14.94 M16.95 M 60.45 M Research & development ————— — Operating income 28.46 M-10.24 M-39.47 M30.85 M-12.31 M -31.17 M Non-Operating Income, Total 8.15 M2.17 M884 K1.5 M6.7 M 11.25 M Interest expense, net of interest capitalized 171.35 M177.68 M184.74 M180.27 M175.2 M 717.89 M Non-Operating Income, excl. Interest Expenses -163.2 M-175.51 M-183.85 M-178.78 M-168.5 M -706.64 M Unusual income/expense ————— — Pretax income 60.47 M53.69 M75.78 M78.43 M46.6 M 254.5 M Equity in earnings -1.63 M2.65 M46.2 M3.66 M4.41 M 56.92 M Taxes 3.59 M3.4 M7.59 M4.2 M2.08 M 17.27 M Non-controlling/minority interest 2.6 M2.02 M3.21 M1.21 M52 K 6.48 M After tax other income/expense ————— — Net income before discontinued operations 43.38 M36.31 M52.02 M26.12 M11.02 M 125.47 M Discontinued operations ————— — Net income 43.38 M36.31 M52.02 M26.12 M11.02 M 125.47 M Dilution adjustment -2.6 M-2.02 M-3.21 M-1.21 M-52 K -6.48 M Preferred dividends 10.34 M10.34 M10.34 M10.34 M10.34 M 41.37 M Diluted net income available to common stockholders 30.44 M23.95 M38.46 M14.57 M629 K 77.62 M Basic earnings per share (Basic EPS) 0.160.120.20.080 0.4 Diluted earnings per share (Diluted EPS) 0.160.120.20.080 0.4 Average basic shares outstanding 190.06 M192.24 M193.75 M192.96 M194.19 M — Diluted shares outstanding 206.86 M209 M210.52 M209.73 M211.74 M — EBITDA -123.45 M-168.04 M-210.04 M-132.4 M-171.29 M -681.77 M EBIT -141.21 M-185.81 M-227.85 M-152.16 M-189.58 M -755.41 M Cost of revenue 23.73 M35.25 M37.45 M10.83 M21.75 M 105.28 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 17.76 M17.77 M17.82 M19.77 M18.29 M 73.65 M